Home AllStripes

AllStripes

acquired
Series B
Developer of New Therapies for Rare Diseases
Basic
Enterprise Profile

Basic Information

AllStripes is a healthcare technology company dedicated to providing new therapies for patients with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate research and drug development for rare diseases, as well as a patient application that enables patients and families to securely participate in online treatment studies and benefit from their own medical data.
AllStripes Research, Inc.
SanFrancisco,California,United States of America
15~50 people
November 01, 2017
nancy@allstripes.com

Enterprise Profile

Industrial Sector
New Drug Development Information Technology Vendors Big Data and Cloud Computing Services CXO (Pharmaceutical Outsourcing Organization)
Technology
Biotechnology
Concept
Rare Diseases Online Consultation Therapeutic Products
Application Scenarios
Smart Healthcare Technical Concepts Innovative Drugs